Bioavailability and potency of natural-source and all-racemic α-tocopherol in the human: A dispute

European Journal of Nutrition

Volumn 39, Issue 5, 2000, Pages 183-193

  Hoppe, P P ^a   Krennrich, G ^a  

^a BASF SE   (Germany)

Author keywords

All racemic tocopherol; Bioavailability; Human; RRR tocopherol

Indexed keywords

ALPHA TOCOPHEROL; NATURAL PRODUCT;

ARTICLE; BIOAVAILABILITY; BLOOD SAMPLING; LIPOPROTEIN METABOLISM; MALABSORPTION; METABOLIC REGULATION; OXIDATIVE STRESS; STEREOISOMERISM; TOTAL PARENTERAL NUTRITION; UMBILICAL CORD BLOOD; VITAMIN METABOLISM;

ANIMALS; BIOLOGICAL AVAILABILITY; DIETARY SUPPLEMENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MEDLINE; REPRODUCIBILITY OF RESULTS; STEREOISOMERISM; VITAMIN E;

EID: 0033754513     PISSN: 14366207     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003940070010     Document Type: Article

References (48)

1. Vitamin E in humans: Demand and delivery
2. Vitamin E status of low birthweight infants fed formula enriched with long-chain polyunsaturated fatty acids
3. Deficiency states, pharmacological effects, and nutrient requirements
4. Stereoisomers of α-tocopheryl acetate. I. Characterization of the samples by physicochemical methods and determination of biological activities in the rat resorption-gestation test
5. Stereoisomers of α-tocopheryl acetate. II. Biopotencies of all eight stereoisomers, individually or in mixtures, as determined by rat resorption-gestation tests
6. Vitamin E: Function and metabolism
7. Relative bioavailability of RRR- and all-rac-alpha-tocopheryl acetate in humans: Studies using deuterated compounds
8. Comparison of plasma α- and γ-tocopherol levels following chronic oral administration of either all-rac-α-tocopheryl or RRR-α-tocopheryl acetate in normal adult male subjects
9. Human plasma and tissue alpha-tocopherol concentrations in response to supplementation with deuterated natural and synthetic vitamin E
10. Relative bioavailabilities of natural and synthetic vitamin E formulations containing mixed tocopherols in human subjects
11. Dose-response comparison of RRR-alpha-tocopherol and all-racemic alpha-tocopherol on LDL oxidation
12. Pharmacokinetics and bioavailability of the RRR and all racemic stereoisomers of alpha-tocopherol in humans after single oral administration
13. Relative biological values of d-a-tocopheryl acetate and all-rac-α-tocopheryl acetate in man
14. Serum concentrations of α-tocopherol after ingestion of various vitamin E preparations
15. Biodiscrimination of α-tocopherol stereoisomers in humans after oral administration
16. Comparison of supplementation of RRR-alpha-tocopherol and racemic alpha-tocopherol in humans: Effects on lipid levels and lipoprotein susceptibility to oxidation
17. Long-term oral vitamin E supplementation in cystic fibrosis patients: RRR-α-tocopherol compared with all-rac-α-tocopheryl acetate preparations
18. Absorption of D- and DL-α-tocopherol in healthy human volunteers
19. Synthetic as compared with natural vitamin E is preferentially excreted as α-CEHC in human urine: Studies using deuterated α-tocopheryl acetates
20. Vitamin E: Antioxidant activity, biokinetics, and bioavailability
21. Bioavailability of vitamin E
22. Tocopherol transport and absorption
23. Absorption, lipoprotein transport and regulation of plasma concentrations of vitamin E in humans
24. Impaired discrimination between stereoisomers of α-tocopherol in patients with familial isolated vitamin E deficiency
25. Discrimination between forms of vitamin E by humans with and without genetic abnormalities of lipoprotein metabolism
26. Regulation of human plasma vitamin E
27. Purification and characterization of the α-tocopherol transfer protein from rat liver
28. Affinity for alpha-tocopherol transfer protein as a determinant of the biological activities of vitamin E analogs
29. Nascent VLDL from liver perfusions of cynomolgus monkeys are preferentially enriched in RRR-compared with SRR-α-tocopherol; studies using deuterated tocopherols
30. Novel urinary metabolite of α-tocopherol, 2,5,7,8-tetramethyl-2(2'carboxyethyl)-6-hydroxychroman, as an indicator of an adequate vitamin E supply?
31. Human plasma vitamin E kinetics demonstrate rapid recycling of plasma RRR-alpha-tocopherol
32. Can we fix norms for C(max) confidence intervals?
33. Biodiscrimination of α-tocopherol stereoisomers in humans after oral administration. Letter to the Editor
34. Reply to Kormann AW, Bachmann H
35. Application of deuterated α-tocopherols to the biokinetics and bioavailability of vitamin E
36. Transport of deuterium-labeled tocopherols during pregnancy
37. Biokinetics of and discrimination between dietary RRR- and SRR-a-tocopherols in the male rat
38. Absorption and transport of deuterium-substituted 2R,4'R,8'R-α-tocopherol in human lipoproteins
39. Biokinetics in humans of RRR-α-tocopherol: The free phenol, acetate ester, and succinate ester forms of vitamin E
40. Evaluation of vitamin E potency. Letter to the Editor
41. Vitamin E. Bioavailability and function of natural and synthetic forms
42. Molecular basis of alpha-tocopherol control of smooth muscle cell proliferation
43. Inhibition of cell proliferation by alpha-tocopherol. Role of protein kinase C
44. Vitamin E and lipid metabolism in man